CCN(Cc1ccccc1)C(=O)Cn1c(=O)n(-c2ccccc2)c(=O)c2c1c1cc(C)ccc1n2C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?